Figure 3From: Comparison of darbepoetin alfa dosed weekly (QW) vs. extended dosing schedule (EDS) in the treatment of anemia in patients receiving multicycle chemotherapy in a randomized, phase 2, open-label trial Kaplan-Meier curve of the time to target hemoglobin from baseline to Week 13. The time to reach the target hemoglobin of ≥11.0 g/dL was similar for both treatment groups.Back to article page